1-5 of 5
Laura S. Jacobus
Close
Sort by
Journal Articles

Complement Factor H Related Protein 1 (CFHR1) Serum Level Correlates With Event-Free Survival In Follicular Lymphoma Patients Treated With Rituximab

Laura M Rogers, PhD, Laura S. Jacobus, MS, Anna M Button, MS, Brian K Link, MD, Thomas M Habermann, MD, Thomas E Witzig, MD, James R Cerhan, MD, PhD, George J. Weiner, MD
Journal: Blood
Blood (2013) 122 (21): 4288.
https://doi.org/10.1182/blood.V122.21.4288.4288
Published: 2013
Journal Articles

Non-Follicular Low Grade B-Cell Lymphomas: Patterns of Presentation and Management with Comparative Prognostic Utility of IPI and FLIPI

Laura S. Jacobus, MS, Julianne Lunde, MA, Matthew J Maurer, MS, Ahmet Dogan, MD, PhD, Sergei I Syrbu, MD, Cristine Allmer, Anne J. Novak, Ph.D., James R Cerhan, MD, PhD, Grzegorz S. Nowakowski, MD, Susan L Slager, PhD, Thomas E. Witzig, MD, Carrie A. Thompson, MD, George J. Weiner, MD, Thomas M Habermann, MD, Stephen M. Ansell, M.D., Ph.D., Brian K Link, MD
Journal: Blood
Blood (2012) 120 (21): 1563.
https://doi.org/10.1182/blood.V120.21.1563.1563
Published: 2012
Journal Articles

IL-21 Plus CpG ODN Induces Granzyme B-Dependent Induction of Apoptosis in CD5-Positive B Cells Including B-CLL Cells.

Sue E. Blackwell, Bernd Jahrsdoerfer, MD, James E. Wooldridge, MD, Jian Huang, Melinda W. Andreski, Laura S. Jacobus, Christiana M. Taylor, George J. Weiner, MD
Journal: Blood
Blood (2006) 108 (11): 2823.
https://doi.org/10.1182/blood.V108.11.2823.2823
Published: 2006
Journal Articles

B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation

Bernd Jahrsdörfer, Sue E. Blackwell, James E. Wooldridge, Jian Huang, Melinda W. Andreski, Laura S. Jacobus, Christiana M. Taylor, George J. Weiner
Journal: Blood
Blood (2006) 108 (8): 2712–2719.
https://doi.org/10.1182/blood-2006-03-014001
Published: 2006
Includes: Supplemental data
Journal Articles

IL-21 and CpG ODN Are Synergistic in Their Ability To Induce Apoptosis of Chronic Lymphocytic Leukemia (CLL) Cells and Benign B1 Cells.

Bernd Jahrsdoerfer, MD, Sue E. Blackwell, James E. Wooldridge, MD, Melinda W. Andreski, Laura S. Jacobus, Christiana M. Taylor, George J. Weiner, MD
Journal: Blood
Blood (2005) 106 (11): 5022.
https://doi.org/10.1182/blood.V106.11.5022.5022
Published: 2005